@article{article_555841, title={Primary Evaluation of Anticancer Activity of Nanocurcumin® Against Human Breast Cancer Cell Line, SkBr3}, journal={International Journal of Nature and Life Sciences}, volume={3}, pages={13–19}, year={2019}, author={Islam, Aminul and Rebello, Leroy and Chepyala, Sreesudha}, keywords={Brest cancer,SkBr3 cell line,Nanocurcumin®}, abstract={<p class="MsoNormal" style="text-align:justify;line-height:150%;"> <span lang="en-us" style="font-family:’Arial Narrow’, ’sans-serif’;" xml:lang="en-us">Breast
cancer is a predominant ailment mostly impairing woman. Against the triple
negative breast cancer xenografts, the curcumin in polymeric micelle form
showed increased bioavailability, cytotoxicity and longer half-life, observed
in <i>in vitro </i>studies (Cridge et al., 2013). In this study, in vitro
anticancer activity of Nanocurcumin <sup>® </sup>was evaluated against human
breast cancer. </span> </p> <p> </p>}, number={1}, publisher={Uğur ÇAKILCIOĞLU}